Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will participate in the ...
Markets recently faced volatility driven by Fed cuts, resilient economic data, and persistent inflation concerns, leading to subdued sentiment. Click to read.